RECENT PLACEMENT

Occam Places Wildon Farwell as CMO of Dyne

Occam Places Wildon Farwell as CMO of Dyne

Dyne Therapeutics, an Atlas Investment, is a platform biotech developing therapeutics across neuromuscular indications.

In early 2021, Occam recruited Wildon Farwell, MD as the company’s CMO. Previously, Wildon held a lengthy career at Biogen, having most recently served as the company’s Global Medical Head for Neuromuscular Diseases.

‍

Recent Placements

  1. Carolyn Haley as COO at F-Prime Capital
  2. Chau Cheng as VP of Investor Relations & Corporate Communications at Cytomx
  3. Bryan Stuart as CEO of Atavistik
  4. Bimal Shah as CFO of Corium
  5. Bell Zhong as CFO at Neomorph
About Occam Global

Occam Global is a trusted executive search, consulting, and investment partner for leaders and investors shaping the future of life sciences, deep tech, and venture capital. Since 2012, we’ve helped build high-performing teams and advised visionary companies from stealth to public markets. Our success stems from exceptional access to rare talent, deep sector expertise, and a commitment to results guided by elevated ethics and enlightened aggression.